SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-16-001638
Filing Date
2016-05-25
Accepted
2016-05-25 18:00:38
Documents
1
Period of Report
2016-05-25

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 9056
  Complete submission text file 0000905148-16-001638.txt   10366
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 CRESCENT COURT SUITE 250 DALLAS TX 75201
Business Address
McGaughy R Kent Jr (Reporting) CIK: 0001402856 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37785 | Film No.: 161675696